Exhibit 12
Abbott Laboratories and Subsidiaries
Computation of Ratio of Earnings to Fixed Charges
(Unaudited)
(dollars in millions)
| | Nine Months Ended | |
| | September 30, 2016 | |
Earnings from Continuing Operations | | $ | 298 | |
Add (deduct): | | | |
Taxes on earnings | | 240 | |
Capitalized interest cost, net of amortization | | (2 | ) |
Noncontrolling interests | | 13 | |
| | | |
Earnings from Continuing Operations, as adjusted | | 549 | |
| | | |
Fixed Charges: | | | |
Interest on long-term and short-term debt | | 278 | |
Capitalized interest cost | | 16 | |
Rental expense representative of an interest factor | | 74 | |
| | | |
Total Fixed Charges | | 368 | |
| | | |
Total adjusted earnings available for payment of fixed charges | | $ | 917 | |
| | | |
Ratio of earnings to fixed charges | | 2.5 | |
NOTE: For the purpose of calculating this ratio, (i) earnings from continuing operations have been calculated by adjusting earnings for taxes on earnings; interest expense; capitalized interest cost, net of amortization; noncontrolling interests; and the portion of rentals representative of the interest factor, (ii) Abbott considers one-third of rental expense to be the amount representing return on capital, and (iii) fixed charges comprise total interest expense, including capitalized interest and such portion of rentals.